ANN MONKEN: Open Payments
NPI 1043724743 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,484 in 58 payments from 17 companies in 2025. Trend: 2023 $1,869 · 2024 $1,232 · 2025 $1,484
Food & beverage: $1,484
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $391 |
| ABBVIE INC. | 14 | $252 |
| Amgen Inc. | 5 | $174 |
| Novo Nordisk Inc | 7 | $143 |
| Axsome Therapeutics, Inc. | 3 | $94 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Lilly USA, LLC | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
Products named: BREZTRI, UBRELVY, REPATHA, AIRSUPRA, Auvelity, REXULTI, Wegovy, VRAYLAR.
Industry payments across IN — which companies pay providers there.
